Back
MoonLake Immunotherapeutics Vs. Aligos Therapeutics Industry Stock Comparison
Sell
20
MLTX
MoonLake Immunotherapeutics
Last Price:
$36.71
Seasonality Move:
-2.28%
Sell
10
ALGS
Aligos Therapeutics
Last Price:
$10.25
Seasonality Move:
-17.78%
Sell
20
MoonLake Immunotherapeutics (MLTX)
is a Sell
Is MoonLake Immunotherapeutics a Buy, Sell or Hold?
-
The current MoonLake Immunotherapeutics [MLTX] share price is $38.04. The Score for MLTX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
MLTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
10
Aligos Therapeutics (ALGS)
is a Sell
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $12.92. The Score for ALGS is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
-
ALGS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
MLTX Stock Price Chart
What is MoonLake Immunotherapeutics's stock price today?
-
The MoonLake Immunotherapeutics share price today is $38.04Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MLTX is experiencing selling pressure, which indicates risk of future bearish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $12.92Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALGS is experiencing slight buying pressure.
MLTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.84 | Sell |
Relative Strength Index (14 RSI): | 31.06 | Sell |
Chaikin Money Flow: | -276146 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.5 - 45.22) | Sell |
Bollinger Bands (100): | (43.81 - 52.69) | Sell |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.88 | Sell |
Relative Strength Index (14 RSI): | 25.39 | Sell |
Chaikin Money Flow: | 90063 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.1 - 25.56) | Sell |
Bollinger Bands (100): | (12.35 - 33.83) | Sell |
MLTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.43 | Sell |
20-day SMA: | 42.2 | Sell |
50-day SMA: | 45.83 | Sell |
200-day SMA: | 46.86 | Sell |
8-day EMA: | 40.12 | Sell |
20-day EMA: | 41.88 | Sell |
50-day EMA: | 44.8 | Sell |
200-day EMA: | 47.13 | Sell |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.13 | Sell |
20-day SMA: | 19.87 | Sell |
50-day SMA: | 28.22 | Sell |
200-day SMA: | 17.74 | Sell |
8-day EMA: | 15.19 | Sell |
20-day EMA: | 18.96 | Sell |
50-day EMA: | 23.24 | Sell |
200-day EMA: | 21.04 | Sell |
MoonLake Immunotherapeutics Earnings Growth & MLTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.03 per share, a decrease this year of $1.42 per share, and a decrease next year of $0.47 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.
MoonLake Immunotherapeutics Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |